EN
HI
Unjha Formulations Share price
UNJHAFOR
27.55
0.00 (0.00%)Last updated on 17 Aug, 2026 | 07:50 IST
Unjha Formulations share price chart
Unjha Formulations Share Key Metrics
Volume
0.00
Market Cap
12.34 CR
LTQ@LTP
0@27.55
ATP
0
Var Margin
100 %
Circuit Range
26.18-28.92
Delivery %
100 %
Value
0.00
ASM/GSM
No
Market Lot
1
Summary
UNJHAFOR stock price is ₹27.55 as of 17 Aug, 2026. The stock intraday movement has stayed between ₹0.00 and ₹0.00, while Unjha Formulations share price 52 week high low is ₹17.52 & ₹29.50.
In terms of trading activity, UNJHAFOR share price has recorded a volume of 0 shares. The Unjha Formulations has a market cap of ₹4480500. The stock’s Average Traded Price (ATP) stands at ₹0.00, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 0 @ ₹27.55.
The Unjha Formulations upper circuit limit is ₹28.92 & The Unjha Formulations lower circuit limit is ₹26.18, with a Value of ₹0.00. The Delivery Percentage for the day is 100%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Unjha Formulations Resistance and Support
Pivot 27.55
Resistance
First Resistance
28
Second Resistance
28.45
Third Resistance
28.9
Support
First Support
27.1
Second Support
26.65
Third Support
26.2
Unjha Formulations Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
36.92%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
63.08%
Others
0%
Total Promoters
MAR '26
36.92%
JUN '26
36.92%
Unjha Formulations Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-18 | Audited Results |
| 2026-02-04 | Quarterly Results |
| 2025-11-10 | Quarterly Results |
| 2025-08-06 | Quarterly Results |
| 2025-05-16 | Audited Results |
| 2025-03-17 | Others |
| 2025-02-04 | Quarterly Results |
| 2024-11-08 | Quarterly Results |
| 2024-08-01 | Quarterly Results |
Unjha Formulations News
Unjha Formulations Ltd - 531762 - Cash Flow Statement For The Year Ended 31.03.2026
Unjha Formulations reported strong financial performance for FY26 with net cash inflow from operations reaching Rs.124.38 crore, a significant turnaround from the Rs.4.49 crore outflow in FY25. The company's cash and cash equivalents also rose to Rs.164.48 crore.
Aug 14 2026 18:39:18
Unjha Formulations Ltd - 531762 - Cash Flow Statement For The Year Ended 31.03.2026
Unjha Formulations reported strong financial performance for FY26 with net cash inflow from operations reaching Rs.124.38 crore, a significant turnaround from the Rs.4.49 crore outflow in FY25. The company's cash and cash equivalents also rose to Rs.164.48 crore.
Aug 14 2026 18:38:25
Unjha Formulations Ltd - 531762 - Publish Audited Financial Results For The Quarter And Year Ended As On 30/06/2026
Unjha Formulations reported a revenue of Rs.3.31 crore for Q1 FY27, marking a 9% year-on-year decline. Net profit significantly dropped by 60% YoY to Rs.0.16 crore, indicating a challenging quarter.
Aug 05 2026 14:28:32
Unjha Formulations Ltd - 531762 - Board Meeting Outcome for Approval Of Un-Audited Financial Results Of The Company For First Quarter Ended On 30Th June ,2026 And Out Come Of Board Meeting Held On 3Rd, August ,2026
Unjha Formulations board approved its Q1 FY26 financial results. The company reported revenue of ₹330.75 lakhs and a net profit of ₹15.69 lakhs for the quarter, both decreasing significantly compared to Q1 FY25. Earnings per share for the period stood at ₹0.35.
Aug 03 2026 15:04:02
Read More
Unjha Formulations Management
| Name | Position |
|---|---|
| Jashodaben S Patel | Chairperson |
| Krutiben M Patel | Managing Director & Compliance Officer |
Unjha Formulations Similar Stocks
Norris Medicines Ltd.
15.90
0.00 (0.00%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Parmax Pharma Ltd.
117.75
0.00 (0.00%)
Colinz Laboratories Ltd.
79.87
0.00 (0.00%)
Broach Lifecare Hospital Ltd.
18.20
0.00 (0.00%)
Starsource Multitrade Ltd.
89.82
0.00 (0.00%)
Ortin Global Ltd.
15.28
0.00 (0.00%)
Kobo Biotech Ltd.
5.13
0.00 (0.00%)
Hindustan Bio Sciences Ltd.
6.93
0.00 (0.00%)
Dolphin Medical Services Ltd.
0.00
0.00 (0.00%)
Unjha Formulations FAQs
The Buying Price of Unjha Formulations share is 27.55 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Unjha Formulations stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Unjha Formulations, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Unjha Formulations shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Unjha Formulations shares is 0. Useful to assess the stock's value relative to its book value.
To assess Unjha Formulations’s valuation compare Sector P/E, P/B which are 63.94 & 3.3 with sector averages, along with growth rates and financial metrics.
The Market Cap of Unjha Formulations is 12.34 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Unjha Formulations share price is 29.50 & 17.52. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Unjha Formulations belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in UNJHAFOR
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC